Delivery Order SPE2DB22D3301-SPE2DB25FY2CE
Award Date
3/24/25
Potential Completion Date
3/25/25
Potential Value
$34K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,344.28 firm fixed-price delivery order contract is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of September 29, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $18,610.80, is a Delivery Order contract for the supply of RENFLEXIS 100 MG VIALS, a medical product, with a completion date of May 13, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,945.14 firm fixed-price delivery order contract is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of June 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $24,625.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RENFLEXIS 100 MG VIALS, a medical product, with a completion date of March 28, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,727.50 firm fixed price delivery order is for the supply of RENFLEXIS 100 MG VIALS medical products. The contract has an ultimate completion date of February 3, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $17,915.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract is not set aside and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award, valued at $4,970.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RENFLEXIS 100 MG VIALS, a pharmaceutical product, with a period of performance through March 10, 2025. This is a firm fixed-price delivery order contract, which means the total price is set in advance and the vendor is responsible for delivering the agreed-upon...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,077.44, is for the delivery of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 23, 2024. The award was not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,074.63 firm-fixed-price delivery order contract is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of May 29, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $21,578.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) vehicle, with a firm fixed-price pricing type. The contract is for the delivery of RENFLEXIS 100 MG VIALS, a pharmaceutical product, to support military healthcare programs. The award has an ultimate completion date of...